The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Breast Cancer Imaging-Global Market Insights and Sales Trends 2024
Synopsis
The global Breast Cancer Imaging market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Breast Cancer Imaging in various end use industries. The expanding demands from the Diagnostic and imaging centers, Hospitals and clinics and Other,, are propelling Breast Cancer Imaging market. Ionizing Technologies, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Non-Ionizing Technologies segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Breast Cancer Imaging market, driven by demand from China, the second largest economy with some signs of stabilising, the Breast Cancer Imaging market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Breast Cancer Imaging, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Breast Cancer Imaging market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Breast Cancer Imaging market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Breast Cancer Imaging sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Breast Cancer Imaging covered in this report include GE Healthcare, Siemens Healthineers, Hologic, Philips Healthcare, Canon Medical, Fujifilm, CMR Naviscan, SonoCine and Dilon Technologies, etc.
The global Breast Cancer Imaging market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GE Healthcare
Siemens Healthineers
Hologic
Philips Healthcare
Canon Medical
Fujifilm
CMR Naviscan
SonoCine
Dilon Technologies
Global Breast Cancer Imaging market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Breast Cancer Imaging market, Segment by Type:
Ionizing Technologies
Non-Ionizing Technologies
Global Breast Cancer Imaging market, by Application
Diagnostic and imaging centers
Hospitals and clinics
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Breast Cancer Imaging companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Breast Cancer Imaging market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Breast Cancer Imaging in various end use industries. The expanding demands from the Diagnostic and imaging centers, Hospitals and clinics and Other,, are propelling Breast Cancer Imaging market. Ionizing Technologies, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Non-Ionizing Technologies segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Breast Cancer Imaging market, driven by demand from China, the second largest economy with some signs of stabilising, the Breast Cancer Imaging market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Breast Cancer Imaging, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Breast Cancer Imaging market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Breast Cancer Imaging market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Breast Cancer Imaging sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Breast Cancer Imaging covered in this report include GE Healthcare, Siemens Healthineers, Hologic, Philips Healthcare, Canon Medical, Fujifilm, CMR Naviscan, SonoCine and Dilon Technologies, etc.
The global Breast Cancer Imaging market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GE Healthcare
Siemens Healthineers
Hologic
Philips Healthcare
Canon Medical
Fujifilm
CMR Naviscan
SonoCine
Dilon Technologies
Global Breast Cancer Imaging market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Breast Cancer Imaging market, Segment by Type:
Ionizing Technologies
Non-Ionizing Technologies
Global Breast Cancer Imaging market, by Application
Diagnostic and imaging centers
Hospitals and clinics
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Breast Cancer Imaging companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Breast Cancer Imaging
1.1 Breast Cancer Imaging Market Overview
1.1.1 Breast Cancer Imaging Product Scope
1.1.2 Breast Cancer Imaging Market Status and Outlook
1.2 Global Breast Cancer Imaging Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Breast Cancer Imaging Market Size by Region (2018-2029)
1.4 Global Breast Cancer Imaging Historic Market Size by Region (2018-2023)
1.5 Global Breast Cancer Imaging Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Breast Cancer Imaging Market Size (2018-2029)
1.6.1 North America Breast Cancer Imaging Market Size (2018-2029)
1.6.2 Europe Breast Cancer Imaging Market Size (2018-2029)
1.6.3 Asia-Pacific Breast Cancer Imaging Market Size (2018-2029)
1.6.4 Latin America Breast Cancer Imaging Market Size (2018-2029)
1.6.5 Middle East & Africa Breast Cancer Imaging Market Size (2018-2029)
2 Breast Cancer Imaging Market by Type
2.1 Introduction
2.1.1 Ionizing Technologies
2.1.2 Non-Ionizing Technologies
2.2 Global Breast Cancer Imaging Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Breast Cancer Imaging Historic Market Size by Type (2018-2023)
2.2.2 Global Breast Cancer Imaging Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Breast Cancer Imaging Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Breast Cancer Imaging Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Breast Cancer Imaging Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Breast Cancer Imaging Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Breast Cancer Imaging Revenue Breakdown by Type (2018-2029)
3 Breast Cancer Imaging Market Overview by Application
3.1 Introduction
3.1.1 Diagnostic and imaging centers
3.1.2 Hospitals and clinics
3.1.3 Other
3.2 Global Breast Cancer Imaging Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Breast Cancer Imaging Historic Market Size by Application (2018-2023)
3.2.2 Global Breast Cancer Imaging Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Breast Cancer Imaging Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Breast Cancer Imaging Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Breast Cancer Imaging Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Breast Cancer Imaging Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Breast Cancer Imaging Revenue Breakdown by Application (2018-2029)
4 Breast Cancer Imaging Competition Analysis by Players
4.1 Global Breast Cancer Imaging Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Breast Cancer Imaging as of 2022)
4.3 Date of Key Players Enter into Breast Cancer Imaging Market
4.4 Global Top Players Breast Cancer Imaging Headquarters and Area Served
4.5 Key Players Breast Cancer Imaging Product Solution and Service
4.6 Competitive Status
4.6.1 Breast Cancer Imaging Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 GE Healthcare
5.1.1 GE Healthcare Profile
5.1.2 GE Healthcare Main Business
5.1.3 GE Healthcare Breast Cancer Imaging Products, Services and Solutions
5.1.4 GE Healthcare Breast Cancer Imaging Revenue (US$ Million) & (2018-2023)
5.1.5 GE Healthcare Recent Developments
5.2 Siemens Healthineers
5.2.1 Siemens Healthineers Profile
5.2.2 Siemens Healthineers Main Business
5.2.3 Siemens Healthineers Breast Cancer Imaging Products, Services and Solutions
5.2.4 Siemens Healthineers Breast Cancer Imaging Revenue (US$ Million) & (2018-2023)
5.2.5 Siemens Healthineers Recent Developments
5.3 Hologic
5.3.1 Hologic Profile
5.3.2 Hologic Main Business
5.3.3 Hologic Breast Cancer Imaging Products, Services and Solutions
5.3.4 Hologic Breast Cancer Imaging Revenue (US$ Million) & (2018-2023)
5.3.5 Philips Healthcare Recent Developments
5.4 Philips Healthcare
5.4.1 Philips Healthcare Profile
5.4.2 Philips Healthcare Main Business
5.4.3 Philips Healthcare Breast Cancer Imaging Products, Services and Solutions
5.4.4 Philips Healthcare Breast Cancer Imaging Revenue (US$ Million) & (2018-2023)
5.4.5 Philips Healthcare Recent Developments
5.5 Canon Medical
5.5.1 Canon Medical Profile
5.5.2 Canon Medical Main Business
5.5.3 Canon Medical Breast Cancer Imaging Products, Services and Solutions
5.5.4 Canon Medical Breast Cancer Imaging Revenue (US$ Million) & (2018-2023)
5.5.5 Canon Medical Recent Developments
5.6 Fujifilm
5.6.1 Fujifilm Profile
5.6.2 Fujifilm Main Business
5.6.3 Fujifilm Breast Cancer Imaging Products, Services and Solutions
5.6.4 Fujifilm Breast Cancer Imaging Revenue (US$ Million) & (2018-2023)
5.6.5 Fujifilm Recent Developments
5.7 CMR Naviscan
5.7.1 CMR Naviscan Profile
5.7.2 CMR Naviscan Main Business
5.7.3 CMR Naviscan Breast Cancer Imaging Products, Services and Solutions
5.7.4 CMR Naviscan Breast Cancer Imaging Revenue (US$ Million) & (2018-2023)
5.7.5 CMR Naviscan Recent Developments
5.8 SonoCine
5.8.1 SonoCine Profile
5.8.2 SonoCine Main Business
5.8.3 SonoCine Breast Cancer Imaging Products, Services and Solutions
5.8.4 SonoCine Breast Cancer Imaging Revenue (US$ Million) & (2018-2023)
5.8.5 SonoCine Recent Developments
5.9 Dilon Technologies
5.9.1 Dilon Technologies Profile
5.9.2 Dilon Technologies Main Business
5.9.3 Dilon Technologies Breast Cancer Imaging Products, Services and Solutions
5.9.4 Dilon Technologies Breast Cancer Imaging Revenue (US$ Million) & (2018-2023)
5.9.5 Dilon Technologies Recent Developments
6 North America
6.1 North America Breast Cancer Imaging Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Breast Cancer Imaging Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Breast Cancer Imaging Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Breast Cancer Imaging Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Breast Cancer Imaging Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Breast Cancer Imaging Market Dynamics
11.1 Breast Cancer Imaging Industry Trends
11.2 Breast Cancer Imaging Market Drivers
11.3 Breast Cancer Imaging Market Challenges
11.4 Breast Cancer Imaging Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
